Skip to content
Wednesday, November 11, 2026
Echonet Online delivers the latest UK technology news, in-d…

The Zimbabwean Government Rejects ‘Unbalanced’ American Healthcare Assistance Agreement Due to Data Fears

Health funding illustration
The proposed American funding was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over Washington's insistence on sensitive data.

The decision came to light following a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "unbalanced".

An official spokesperson has since explained that the US was seeking health data for scientific study and commercial purposes while was not willing to guarantee the benefits from future medical innovations.

"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy noted the United States had donated over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged continued dialogue to reach a deal suitable to both sides so the country's critical HIV treatment initiative can proceed.

Wider Context

This rejection comes after a comparable situation in Kenya, where a court blocked a similar health funding agreement following concerns were filed about the security of Kenyans' health data.

After returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.

According to reports, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this partnership would have delivered immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," Tremont said.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.

"Effectively, our country would provide the raw materials for scientific discovery without any certainty that the resulting innovations would be available to our people should a new disease outbreak arise."

National Interest and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending systems already set up through the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.

"This framework is designed to ensure that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.

"We welcome ongoing discussions with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Reaction

A leading public health body expressed it recognised the government's concerns, but urged that talks must proceed considering much of the country's Aids initiatives relied on foreign aid.

"If specific concerns exist, including those relating to information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it commented.

This impasse highlights the complex challenges between accepting much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.

About the author

Daniel Perez

A UK-based tech journalist with over a decade of experience covering consumer electronics and digital innovation.

Echonet Online

Type to search articles.